Jatenzo Storage, Stability & Shelf Life

How Jatenzo Works: The SEDDS Formulation Explained

Jatenzo uses a self-emulsifying drug delivery system (SEDDS) to solve a problem that kept oral testosterone off the U.S. market for decades: poor and erratic bioavailability through the portal circulation. The capsule contains testosterone undecanoate dissolved in a proprietary lipid vehicle composed of medium-chain fatty acids. When the capsule is swallowed with food, the lipid matrix emulsifies in the small intestine and promotes absorption through the intestinal lymphatic system, largely bypassing first-pass hepatic metabolism [1].

This lymphatic absorption pathway is what separates Jatenzo from older oral androgens like methyltestosterone, which pass directly through the liver and carry hepatotoxicity risk. The SEDDS technology depends on intact lipid excipients inside a moisture-sensitive soft gelatin shell. That dependency is exactly why storage conditions matter more for Jatenzo than for injectable testosterone formulations. If the lipid matrix degrades or the gelatin shell loses integrity, the self-emulsifying process fails and drug absorption drops unpredictably [2].

The FDA-approved prescribing information specifies twice-daily dosing with food, starting at 237 mg. In the key phase 3 trial by Swerdloff et al. (N=166), 87% of men with hypogonadism achieved serum testosterone concentrations within the normal range (300 to 1,100 ng/dL) by 3 months of treatment [1]. Those efficacy results assume the capsules were stored and handled per protocol. Compromised capsules may not deliver consistent drug exposure.

FDA-Labeled Storage Conditions

The labeled storage requirement is straightforward: keep Jatenzo at controlled room temperature, defined by the USP as 20°C to 25°C (68°F to 77°F). Temporary excursions to 15°C to 30°C (59°F to 86°F) are acceptable [2].

The USP General Chapter <659> defines "controlled room temperature" with a mean kinetic temperature (MKT) calculation that accounts for fluctuations over time. A brief spike to 84°F during a summer afternoon does not violate this standard, provided the average remains within range. Sustained exposure above 86°F, however, exceeds the tested excursion window and may accelerate degradation of both the gelatin shell and the lipid fill [3].

Patients should store the bottle in a climate-controlled room, away from bathrooms (where humidity spikes during showers) and away from kitchen counters near stoves or ovens. Car gloveboxes and mailboxes are two of the most common real-world locations where medications exceed labeled temperature limits. A 2018 study published in the Journal of Managed Care & Specialty Pharmacy found that interior car temperatures can reach 130°F within 60 minutes on a 90°F day, far exceeding any permitted excursion range [4].

Chemical Stability of Testosterone Undecanoate

Testosterone undecanoate is an ester prodrug. The undecanoate side chain is hydrolyzed in vivo to release active testosterone. Outside the body, this ester bond is relatively stable under dry, temperate conditions but susceptible to hydrolysis when exposed to moisture and heat simultaneously [5].

The ICH Q1A(R2) guideline requires pharmaceutical manufacturers to conduct long-term stability testing at 25°C/60% relative humidity and accelerated testing at 40°C/75% RH over six months. Tolmar's stability data, submitted as part of the NDA 206089 approval package, supported a 36-month expiration date under labeled conditions [2].

The lipid excipients in the SEDDS fill present their own stability considerations. Oxidative rancidity of the medium-chain triglycerides can alter the emulsification profile, reducing the rate and extent of lymphatic uptake. Peroxide values and acid numbers are standard quality markers tracked during stability studies for lipid-based formulations. Published data on similar SEDDS formulations show that antioxidants in the fill (typically alpha-tocopherol) maintain lipid integrity for 24 to 36 months at controlled room temperature, but degrade within 3 to 6 months at 40°C/75% RH [6].

Patients who notice capsules that are stuck together, leaking oil, discolored, or have an unusual odor should not take them. These are visible signs that the formulation has been compromised.

Soft Gelatin Capsule Integrity

The gelatin shell is the first barrier between the environment and the lipid drug fill. Soft gelatin capsules absorb moisture from humid air. That absorption causes the shell to soften, become tacky, and eventually fuse with neighboring capsules in the bottle. This phenomenon, called "capsule blooming" or pellicle formation, is well documented in pharmaceutical literature [7].

Conversely, very low humidity causes gelatin to become brittle and crack. The USP General Chapter <1151> on pharmaceutical dosage forms notes that soft gelatin capsules perform best between 30% and 65% relative humidity [3]. Patients living in arid climates (the desert Southwest, for example) should keep bottles tightly closed and avoid leaving capsules loose in pill organizers for more than 24 to 48 hours.

Cross-linking is another gelatin-specific degradation pathway. Aldehydes released from degrading fill excipients or from the gelatin itself can cause the shell to form an insoluble pellicle. This pellicle slows dissolution and may reduce drug release in the GI tract. The FDA's guidance on dissolution testing of gelatin capsules acknowledges this risk and permits the use of enzymes (pepsin or papain) in dissolution media when cross-linking is suspected [8].

For Jatenzo specifically, the soft gel shell must dissolve rapidly enough to release the SEDDS fill into the duodenum where fat absorption occurs. A compromised shell that dissolves too slowly shifts the release window further down the GI tract, past the primary lymphatic absorption site.

Practical Storage Recommendations for Patients

Keep the capsules in the original bottle. The manufacturer's container includes a desiccant packet and a child-resistant cap designed to limit moisture ingress. Transferring capsules to weekly pill organizers removes both protections.

Five rules for safe storage:

1. Store the bottle in a bedroom drawer or closet shelf, not a bathroom medicine cabinet.
2. Replace the cap tightly after each use.
3. Do not remove the desiccant packet from the bottle.
4. If a capsule feels soft, sticky, or looks swollen, discard it.
5. Check the expiration date printed on the bottle before starting a refill, especially for 90-day mail-order supplies.

Mail-order pharmacy shipments deserve extra attention. Packages sitting on a porch in summer heat or in a freezing mailbox during winter may exceed excursion limits. The National Association of Boards of Pharmacy (NABP) has flagged temperature excursion risks for mail-order controlled substances [4]. Patients using mail order should request temperature-controlled shipping or arrange for prompt retrieval.

The Jatenzo REMS and Dispensing Chain Implications

Jatenzo carries a Risk Evaluation and Mitigation Strategy (REMS) because of the cardiovascular risk signal associated with oral testosterone formulations. The Jatenzo REMS program restricts dispensing to specially certified pharmacies that have completed training [9].

This restricted distribution has a practical upside for storage quality. Certified pharmacies handle smaller volumes of Jatenzo and are audited on storage compliance. The supply chain is shorter compared to mass-market generics, reducing the time capsules spend in warehouses or delivery trucks where temperature control may be inconsistent. The REMS requirement effectively creates a tighter custody chain from manufacturer to patient.

The tradeoff is reduced pharmacy competition, which limits where patients can fill prescriptions. Some patients receive Jatenzo through specialty mail-order pharmacies operated by the REMS-certified network. These pharmacies typically ship with insulated packaging and cold-chain monitoring, a standard practice for specialty drugs but not universal for all mail-order medications.

Shelf Life: What 36 Months Means in Practice

The 36-month shelf life begins at manufacture, not at dispensing. A bottle that sat in a distributor warehouse for 12 months before reaching the pharmacy already has only 24 months of labeled shelf life remaining when dispensed.

Pharmacies are required to dispense medications with adequate remaining shelf life, but no federal regulation specifies a minimum. The FDA's guidance on expiration dating notes that expiration dates reflect the last date the manufacturer guarantees full potency and safety under labeled conditions [10]. After expiration, the drug does not necessarily become toxic, but potency cannot be assured.

For a testosterone replacement therapy that patients take twice daily to maintain physiologic testosterone levels, subpotent capsules mean subtherapeutic serum testosterone. A man relying on Jatenzo for hypogonadism treatment could experience symptom recurrence (fatigue, low libido, mood changes) if degraded capsules deliver inconsistent drug exposure.

"Testosterone undecanoate oral formulations depend on intact lipid-based excipients for lymphatic absorption. Thermal or oxidative stress to the capsule contents can reduce bioavailability even when the active pharmaceutical ingredient remains chemically intact," according to a 2020 review in the Journal of Clinical Endocrinology & Metabolism [1].

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy for men with hypogonadism recommends monitoring serum testosterone levels 3 to 6 months after initiating any new testosterone formulation [11]. This monitoring interval serves as a clinical safety net. If storage-related degradation has reduced drug delivery, follow-up labs will reveal subtherapeutic levels before prolonged symptom exposure.

Comparing Storage Requirements Across Testosterone Formulations

Jatenzo's storage profile is more sensitive than injectable testosterone cypionate or enanthate, which are oil-based solutions in sealed glass vials. Injectable formulations tolerate wider temperature ranges and have no gelatin shell to degrade. Testosterone gels (AndroGel, Testim) are similarly stable at room temperature but are flammable due to alcohol content, adding a fire-safety consideration that Jatenzo does not share.

Testosterone pellets (Testopel) are implanted subcutaneously and stored by clinics in sealed foil pouches. Their stability profile is largely irrelevant to patients post-implantation. Transdermal patches store at room temperature with no special humidity concerns.

Among oral formulations specifically, the original testosterone undecanoate product marketed outside the U.S. (Andriol) used an oleic acid and propylene glycol laurate fill in soft gelatin capsules and required refrigeration at 2°C to 8°C [12]. Jatenzo's reformulated SEDDS fill eliminated the cold-chain requirement, a significant practical improvement for patient adherence and pharmacy logistics. The Swerdloff et al. trial validated the reformulated product's efficacy at room-temperature storage [1].

"The SEDDS formulation of testosterone undecanoate represents a meaningful advance in oral androgen delivery because it supports room-temperature storage while achieving reliable lymphatic absorption," noted Dr. Ronald Swerdloff in the phase 3 trial publication [1].

Travel and Transport Considerations

Patients traveling with Jatenzo face the same challenges as anyone carrying temperature-sensitive medication. The TSA permits prescription medications in carry-on luggage, and carrying Jatenzo in the cabin avoids the extreme temperature swings of aircraft cargo holds, which can drop below freezing at altitude.

For road trips, keep the bottle inside an insulated bag (not directly on ice, as freezing may damage the gelatin shell). Hotel rooms with functioning air conditioning maintain acceptable temperature ranges. Extended camping trips or outdoor expeditions in extreme heat present genuine risk. A portable medication cooler with phase-change packs can maintain 68°F to 77°F for 24 to 48 hours.

Patients crossing international borders should carry the original pharmacy-labeled bottle and a copy of the prescription. Testosterone undecanoate is a Schedule III controlled substance in the United States under the Controlled Substances Act, and regulations vary by country [9].

When to Contact Your Prescriber About Storage Concerns

If capsules have been exposed to temperatures above 86°F for more than a few hours (left in a hot car, delivered to an unshaded porch in summer), contact your pharmacy. If capsules show any physical changes (softening, color change, oily residue on the outside, unusual smell), do not take them. Request a replacement supply.

If you suspect compromised capsules contributed to a period of symptom return, your prescriber can order a trough serum testosterone level (drawn in the morning before your first dose of the day) to check whether drug exposure remains therapeutic. The target trough range per the Jatenzo prescribing information is 300 to 1,050 ng/dL. Levels below 300 ng/dL on a stable dose warrant investigation into adherence, absorption, or medication integrity.